AngioDynamics Inc. ANGO) on Wednesday reported a loss of $10.7 million in its fiscal second quarter. On a per-share basis, the Latham, New York-based company said it had a loss of 26 cents.

AngioDynamics (ANGO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.05 per share a year ago. These figures are ...

AngioDynamics Inc. (ANGO) revealed Loss for second quarter that decreased from last year but beat the Street estimates. The ...

AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q2 2025 earnings on Jan 8, 2025. The consensus estimate for Q2 2025 ...

Attendees will gain insights into the NanoKnife System’s proprietary irreversible electroporation (IRE) technology and how it is poised to become the standard, function-preserving treatment for men ...

The Southern Kaduna Journalists' Forum (SKJF) has lauded President Bola Ahmed Tinubu for approving the establishment of a ...

S&P 500 E-Mini futures (ESH25) are trending down -0.02% this morning as investors awaited the Federal Reserve’s December ...

The Northern Elders’ Forum (NEF) on Saturday, demanded immediate suspension of the proposed Tax Reform Bills. The convener of NEF, Professor Ango Abdullahi, had in a communique issued after the ...

He urged the Federal Government to emulate past responses to similar tragedies, such as in Tudun-Beri, Kaduna, by ...

Buy ANGO near 8.84 target n/a stop loss @ 8.81. Details The technical summary data tells us to buy ANGO near 8.84, but there is no current upside target from the summary table. In this case we should ...

The Centre for Reform and Public Advocacy has kicked against the moves by the Federal Capital Territory Internal Revenue Service, FCT -IRS, to collect all ...